Diabetes as a risk factor to cancer: Functional role of fermented papaya preparation as phytonutraceutical adjunct in the treatment of diabetes and cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 768, Issue C, 2014, Pages 60-68

  Aruoma, Okezie I ^a   Somanah, Jhoti ^b   Bourdon, Emmanuel ^c   Rondeau, Philippe ^c   Bahorun, Theeshan ^b  

^a American University of Health Sciences   (United States)

^b UNIVERSITY OF MAURITIUS   (Mauritius)

^c UNIVERSITÉ DE LA RÉUNION   (France)

Author keywords

Diabetes and cancer treatment; Fermented papaya preparation; Hyperglycaemia and hyperinsulinaemia; Modulation cancer therapy side effects; Oxidative stress and antioxidants; Oxidative stress and inflammation

Indexed keywords

EID: 84899771592     PISSN: 00275107     EISSN: 18792871     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2014.04.007     Document Type: Review

References (83)

1. Cnop M., Welsh N., Jonas J.C., Jörns A., Lenzen S., Eizirk D.L. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes. Many differences, few similarities. Diabetes 2005, 54:S97-S107.
2. Gleason C.E., Gonzalez M., Harmon J.S., Robertson R.P. Determinants of glucose toxicity and it reversibility in pancreatic islet beta-cell line HIF-TIS. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E997-E1002.
3. Stattin P., Björ O., Ferrari P., Kukanova A., Lenner P., Lindhal B., Hallmans G., Kaaks R. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007, 30:561-567.
4. Seshasai S.R., Kaptoge S., Thompson A., Angelantonio E., Gao P., Sarwar N., Whincup P.H., Mukamal K.J., et al. Diabetes mellitus, fasting glucose and risk of cause specific death. N. Engl. J. Med. 2011, 364:829-841. Emerging risk factors collaboration.
5. Hamanaka R.B., Chandel N.S. Targeting glucose metabolism for cancer therapy. J. Exp. Med. 2012, 209:211-215.
6. Cohen D.H., LeRoith D. Obesity, type 2 diabetes and cancer: the insulin and IGF connection. Endocr. Relat. Cancer 2012, 19:F27-F45.
7. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M.E., Koo J., Madarnas Y., Hartwick W., Hoffma B., Hood N. Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study. J. Clin. Oncol. 2002, 20:42-51.
8. Rowlands M.A., Gunnell D., Harris R., Vatten L.J., Holly J.M.P., Martin R.M. Circulating insulin like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis. Int. J. Cancer 2009, 124:2416-2429.
9. Arcidiacono B., Liritano S., Nocera A., Possidente K., Nevolo M.T., Ventura V., Foti D., Chiefari E., Brunetti A. Insulin resistance and cancer risk: an overview of the pathogenic mechanisms. Exp. Diabetes Res. 2012, 12. (Article ID 789174).
10. Neergheen-Bhujun V.S., Kang K.S., Aruoma O.I., Bahorun T. Dietary Biofactors in the Management of Cancer: Myth or Reality?. In Nutrition, Diet and Cancer 2012, 109-128. Springer Dordrecht Heidelberg, London, New York. S. Shankar, R.K. Srivastava (Eds.).
11. Ernest E. The role of complementary and alternative medicine. BMJ 2000, 132:1133.
12. Barnes P.M., Powell-Griner E., McFann K., Nahin R.L. Complementary and alternate medicine use amongst adults in the US. Sem. Integ. Med. 2004, 2:54-57.
13. Cooper A.J., Sharp S.J., Lentjes M.A.H., Luben R.N., Khaw K.T., Wareham N.J., Forouhi N.G. A prospective study of the association between quantity and variety of fruit and vegetable intake and incidence of type 2 diabetes. Diabetes Care 2012, 35:1293-1300.
14. Eliassen A.H., Hendrickson S.J., Brinton L.A., Buring J.E., Campos H., Dai Q., Dorgan J.F., Franke A.A., Gao Y.T., et al. Circulating carotenoids and risk of breast cancer: pooled analysis of 8 prospective studies. J. Natl. Cancer Inst. 2012, 104:1905-1916.
15. Aruoma O.I. Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol. 1994, 32:671-683.
16. Santiago L.A., Osato J.A., Mori A. Stability of the hydroxyl radical scavenging components of the health food Immun'Age. Med Sci. Res. 1992, 20:27-28.
17. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a casual role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
18. Gupta S.C., Hevia D., Patchva S., Park B., Koh W., Aggarwal B.B. Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, Prevention and Therapy. Antioxid. Redox Signal. 2012, 16:1296-1392.
19. Cobbs C.S., Whisenhunt T.R., Wesemann D.R., Harkins L.E., Van Meir E.G., Samanta M. Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells. Cancer Res. 2003, 63:8670-8673.
20. Dreher D., Junod A.F. Role of oxygen free radicals in cancer development. Eur. J. Cancer 1996, 32A:30-38.
21. Kajimoto Y., Kaneto H. Role of oxidative stress in pancreatic beta cell dysfunction. Ann. N.Y. Acad. Sci. 2004, 1011:168-176.
22. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell Biol. 2008, 15:247-254.
23. Dröge W. Free radicals in the physiological control of cell function. Arch. Biochem. Biophys. 2002, 430:37-48.
24. Hancock J.T., Desikan R., Neill S.J. Role of reactive oxygen species in cell signaling pathways. Biochem. Soc. Trans. 2001, 29:345-350.
25. Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?. Nat. Rev. Drug Discov. 2009, 8:579-591.
26. Sumi D., Shinkai Y., Kumagai Y. Signal transduction pathways and transcription factors triggered by arsenic trioxide in leukemia cells. Toxicol. Appl. Pharmacol. 2010, 244:385-392.
27. Otsuki N., Dang N.H., Kumagai E., Kondo A., Iwata S., Morimoto C. Aqueous extract of Carica papaya leaves exhibits anti-tumor activity and immunomodulatory effects. J. Ethnopharmacol. 2010, 127:760-767.
28. Li Z-Y., Wang Y., Shen W-T., Zhou P. Content determination of benzyl glucosinolate and anti-cancer activity of its hydrolysis product in Carica papaya L. Asian Pac. J. Trop. Med. 2012, 231-233.
29. Nguyen T.T.T., Shaw P.N., Marie-Odile Parat M.-O., Amitha K., Hewavitharana A.K. Anticancer activity of Carica papaya: a review. Mol. Nutr. Food Res. 2013, 57:153-164.
30. Zhang J., Webb D.J., Maxwell S.R.J. Fermented papaya preparation attenuates β-amyloid precursor protein: β-amyloid-mediated copper neurotoxicity in β-amyloid precursor protein and β-amyloid precursor protein Swedish mutation over-expressing SH-SY5Y cells. Neuroscience 2006, s143:63-72.
31. Lamb R.E., Goldstein B.J. Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance and vascular function. Int. J. Clin. Pract. 2008, 62:1087-1095.
32. Crujeiras A.B., Diaz-Lagares A., Carreira M.C., Amil M., Casnueva F.F. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic. Res. 2013, 47:243-256.
33. Aruoma O.I., Colognato R., Fontana I., Gartlon J., Migliore L., Koike K., Coecke S., Lamy E., Mersch-Sundernann V., Laurenz I., Benzi L., Yoshino F., Kobayashi K., Lee M.C. Molecular effects of a fermented papaya preparation on oxidative damage, MAP kinase activation and modulation of the benzo[a]pyrene mediated genotoxicity. Biofactors 2006, 26:147-159.
34. Yoshino F., Lee M.C.I., Kobayashi K., Hayashi Y., Aruoma O.I. Assessment of the effect of a fermented papaya preparation on oxidative damage in spontaneously hypertensive rat (SHR) brain using electron spin resonance (ESR) imaging and L-band spectroscopy. J. Funct. Food 2009, 1:375-380.
35. Imao K., Wang H., Komatsu M., Hiramatsu M. Free radical scavenging activity of fermented papaya preparation and its effect on lipid peroxide level and superoxide dismutase activity in iron-induced epileptic foci of rats. Biochem. Mol. Biol. Int. 1998, 45:11-23.
36. Haramaki N., Marcocci L., D'Anna R., Yan L-J., Kobuchi H., Packer L. Fermented papaya preparation supplementation effect on oxidative stress to isolated hearts. Biochem. Mol. Biol. Int. 1995, 36:1039-1097.
37. Marcocci L., D'Anna R., Yan L.-J., Haramaki N., Packer L. Efficacy of Bio-Catalyzer α.ρ no.11 (Bio-Normalizer) supplementation against peroxyl radical-induced oxidative damage in rat organ homogenates. Biochem. Mol. Biol. Int. 1996, 38:535-541.
38. World Health Organization Guidelines for drinking water quality. Health Criteria and Other Supporting Information 1996, vol. 2. World Health Organization, Geneva. 2nd ed.
39. Toyokumi S. Role of iron in carcinogenesis: cancer as a ferotoxic disease. Cancer Sci. 2009, 100:9-16.
40. Deiana M., Rosaa A., Casua V., Pigaa R., Dessiỳa M.A., Aruoma O.I. l-Ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids. Clin. Nutr. 2004, 23:183-193.
41. Rimbach G., Guo Q., Akiyama T., Matrugo S., Moini H., Virgili F., Packer L. Ferric nitriloacetate induced DNA and protein damage. Anticancer Res. 2000, 5A:2907-2914.
42. Marotta F., Yoshida C., Barreto R., Naito Y., Fesce F., Packer L. Oxidative-inflammatory damage in cirrhosis: effect of vitamin E and a fermented papaya preparation. J. Gastroenterol. Hepatol. 2007, 22:697-703.
43. Marotta F., Barreto R., Tajiri H., Bertuccelli J., Safran P., Yoshinda C., Fesce E. The aging/pre cancerous gastric mucosa: a pilot nutraceutical trial. Ann. N. Y. Acad. Sci. 2004, 1019:195-199.
44. Aruoma O.I., Yuki H., Marotta F., Mantello P., Rachmilewitz E.A., Montagnier L. Applications and bioefficacy of the functional food supplement fermented papaya preparation. Toxicology 2010, 278:75-87.
45. Marotta F., Koike K., Lorenzetti A., Jain S., Signorelli P., Metugriachuk Y., et al. Regulating redox balance gene expression in healthy individuals by nutraceuticals: a pilot study. Rejuv. Res. 2010, 13:175-178.
46. Marotta F., Chui D.H., Jain S., Polimeni A., Koike K., Zhou L., Lorenzetti A., Shimizu H., Yang H. Effect of a fermented nutraceutical on thioredoxin level and TNF-alpha signaling in cirrhosis patients. J. Biol. Regul. Homeost. Agents 2011, 25:37-45.
47. Adeneye A.A., Olagunju J.A., Banjo A.A.F., Abdul S.F., Sanusi O.A., Sanni O.O., Osarodion B.A., Shonoiki O.E. The aqueous seed extract of Carica papaya Linn. Prevents carbon tetrachloride induced hepatotoxicity in rats. Int. J. Appl. Res. Nat. Prod. 2009, 2:19-32.
48. Nwangwa W.K. Dose-dependant attenuating effects of aqueous extract of Carica papaya seed on carbon tetrachloride induced renal toxicity in rats. Adv. Life Sci. 2012, 2:124-127.
49. Collen E.B., Mayer M.N. Acute effects of radiation treatment: skin reactions. Can. Vet. J. 2006, 47:931-935.
50. Pasqualotto F.F., Agarwal A. Radiation effects on spermatogenesis. Fertility Preservation in Male Cancer Patients 2013, 104-109. Cambridge University Press. J.P. Mulhall, L.D. Applegarth, R.D. Oates, P.N. Schlegel (Eds.).
51. Wang Y., Lui L., Pazhanisamy S.K., Li H., Meng A., Zhou D. Total body irradiation causes residual bone marrow injury by induction of persistent oxidatives stress in murine hematopoietic stem cells. Free Radic. Biol. Med. 2010, 48:348-356.
52. Dale P.S., Tamhankar C.P., George D., Daftary G.V. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother. Pharmacol. 2001, 29-34.
53. Korkindel L., Osato J.A., Chivilyema I., Samocravyova E., Cheremisina Z., Afanas'ev I. Radioproetctive and antioxidant effects of zinc aspartate and FPP in children with acute myelo-iympholeukemia. Nutrition 1995, 11:555-558.
54. Oloyede O., Roos D., Rocha J. Studies on the antioxidant potentials of extracts from unripe fruit of Carica papaya. J. Life Sci. 2012, 6:41-47.
55. Fibach E., Tan E.S., Jamuar S., Ng I., Amer J., Rachmilewitz E.A. Amelioration of oxidative stress in red blood cells from patients with β-thalassemia major and intermedia and E-β-thalassemia following administration of a fermented papaya preparation. Phytother. Res. 2010, 24:1334-1338.
56. Amer J., Goldfarb A., Rachmilewitz E.A., Fibach E. Fermented papaya preparation as a redo regulator in blood cells of β-thalassemic mice and patients. Phytother. Res. 2008, 22:820-828.
57. Somanah J., Aruoma O.I., Gunness T.K., Kowelssur S., Dambala V., Murad F., Googoolye K., Daus D., Indelicato J., Bourdon E., Bahorun T. Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Mauritian population. Prev. Med. 2012, 54:S90-S97.
58. Giovannucci E., Harlan D.M., Archem C., Bergenstal R.M., Gupstur S.M., Habel L.A., Pollak M., Regensteiner J.G., Yee D. Diabetes and cancer: a consensus report. Diabe Care 2010, 33:1674-1685.
59. Nguyen Q.T., Sanders L., Micheal A.P., Anderson S.R., Nguyen L.D., Johnson Z.A. Diabetes medications and cancer risk: review of literature. Am. Health Drug Benefits 2012, 5:221-229.
60. Azoulay L., Yin H., Filion K.B., Assayag J., Majdan A., Pollack M.N., Suissa S. The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case control study. BMJ 2012, 344:e3645.
61. Suzuki S., Arnold L.L., Pennington K.L., Kakluchi-Kiyota S., Wei M., Wannibuchi H., Cohen S.M. Effects of pioglitazone, a peroxisome proliferator activated receptor gamma agonist on the urine and urothelium of rat. Toxicol. Sci. 2010, 113:349-357.
62. Thakkar B., Aronis K.N., Vamvini M.T., Shields K., Mantzoros C.S. Metformin and sulfonylureas in relation to cancer risk in type 2 diabetes patients: a meta-analysis using primary data of published studies. Metabolism 2013, 62:922-934.
63. Ruiter R., Visser L.E., Van Herk-Sukel M.P., Coebergh J.W., Haak H.P., Geelhoed-Duijvestijin P.H., Straus S.M., Herings R.M., Stricker B.H. Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population based follow up study. Diabetologia 2012, 55:51-62.
64. Luo J., Chelbourski R., Wactawski-Wende J., Schlecht N.F., Tinker L., Margolis K.L. Diabetes and lung cancer amongst pre-menopausal women. Diabet Care 2012, 35:1485-1491.
65. Libby G., Donnelly L.A., Donnan P.T., Alessi D.R., Morris A.D., Evans J.M.M. New users of metformin are at a low risk of incidence cancer. Diabet Care 2009, 22:2640-2645.
66. Zakikhani M., Dowling R., Fantus I.G., Sonenberg N., Pollak M. Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 2006, 66:10267-10273.
67. Pandeya K.B., Tripathi I.P., Mishra M.K., Dwivedi N., Pardhi Y., Kamal A., Gupta P., Dwivedi N., Mishra C. A critical review on traditional herbal drugs: an emerging alternative drug for diabetes. Int. J. Org. Chem. 2013, 3:1-22.
68. Chang C.L.T., Lin Y., Bartolom A.P., Chen Y.-C., Chiu S.-C., Yang W.-C. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid. Based Complement. Alternat. Med. 2013, 33. (Article ID 378657).
69. Oboh G., Olabiyi A.A., Akinyemi A.J., Ademiluyi A.O. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside-induced lipid peroxidation in rat pancreas by water-extractable phytochemicals from unripe pawpaw fruit (Carica papaya). J. Basic Clin. Phys. Pharmacol. 2013, 1-14.
70. Canini A., Alesiani D., D'Arcangelo G., Tagliatesta P. Gas chromatography-mass spectrometry analysis of phenolic compounds from Carica papaya L. leaf. Food Compos. Anal. 2007, 20:584-590.
71. Erukainure O.L., Ebuehi O.A.T., Adeboyejo F.O., Okafor E.N., Muhammad A., Elemo G.N. Fiber-enriched biscuit enhances insulin secretion, modulates β-cell function, improves insulin sensitivity, and attenuates hyperlipidemia in diabetic rats. Pharma Nutr. 2013, 1:58-64.
72. Maniyar Y., Bhixavatimath P. Anti-hyperglycemic and hypolipidemic activities of aqueous extract of Carica papaya Linn. Leaves in alloxan-induced diabetic rats. J. Ayurveda Integr. Med. 2012, 3:70-74.
73. Danese C., Espoisto D., D'alfonso V., Civene M., Ambrosino M., Colotto M. Plasma glucose level decreases as a collateral effect of fermented papaya preparation use. Clin. Ther. 2006, 157:195-198.
74. Collard E., Roy S. Improved function of diabetic wound-site macrophages and accelerated wound closure in response to oral supplementation of a fermented papaya preparation. Antioxid. Redox Signal. 2010, 13:599-606.
75. Fauziya S., Krishnamurthy R. Papaya (Carica papaya): source material for anticancer CIBTech. J. Pharm. Sci. 2013, 2:25-34.
76. Kobuchi H., Packer L. Immun'Age modulates interferon-γ induced nitric oxide production in the mouse macrophage cell line RAW 264.7. Biochem. Mol. Biol. Int. 1997, 43:141-152.
77. Rimbach G., Park Y.C., Guo Q., Moini H., Quershi N., Saliou C., Takayama K., Virgilli F., Packer L. Nitric oxide synthesis and TNF-α secretion in RAW 267.7 macrophages: mode of action of a fermented papaya preparation. Life Sci. 2000, 67:679-694.
78. Schaper N.C., Apelqvist J., Baker K. Reducing lower leg amputations in diabetes: a challenge for patients, healthcare providers and the healthcare system. Diabetologica 2012, 55:1869-1872.
79. Brem H., Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J. Clin. Invest. 2007, 117:1219-1222.
80. Blakytny R., Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabetic Med. 2006, 23:594-608.
81. Mahmood A.A.K., Sidik K., Salmah I. Wound healing activity of Carica papaya L. aqueous leaf extract in rats. Int. J. Mol. Med. Adv. Sci. 2005, 1:398-401.
82. Ocloo A., Nwokolo N.C., Dayie N.T.K.D. Phytochemical characterization and comparative efficacies of crude extracts of Carica papaya. Int. J. Drug Res. Technol. 2012, 2:399-406.
83. Ranc K., Jorgensen M.E., Friis S., Carstensen B. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia 2014, 10.1007/s00125-014-3186-z.